Hostname: page-component-586b7cd67f-g8jcs Total loading time: 0 Render date: 2024-11-27T19:26:06.909Z Has data issue: false hasContentIssue false

Building Racial and Gender Equity into a National PrEP Access Program

Published online by Cambridge University Press:  29 July 2022

Rights & Permissions [Opens in a new window]

Abstract

Transgender and gender diverse (TGD), Black, and Latinx communities have long borne a disproportionate share of the U.S. HIV epidemic, yet these same key demographics are continually underrepresented in national PrEP prescriptions. Black, Latinx, and TGD individuals are also more likely to be uninsured, meaning that a proposed federal program to cover PrEP for people without insurance could provide significant benefit to potential PrEP users from these populations. However, coverage of PrEP costs alone will not end disparities in uptake. This commentary provides additional context and recommendations to maximize effectiveness of a national PrEP program for TGD, Black, and Latinx populations in the US.

Type
Commentary
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© 2022 The Author(s)

The U.S. HIV epidemic is a case study of health disparities. While there have been reductions in incidence in recent years for white Americans, Black and Latinx communities have seen their epidemics stagnate or worsen. Black populations made up 29% of new infections in 1981 and 41% of new infections in 2019.Reference Bosh, Hall, Eastham, Daskalakis and Mermin 1

Hispanic/Latino individuals made up 16% of new infections in 1981 and 29% of new infections in 2019. 2 There are also high rates of HIV in transgender and gender diverse individuals. It is no coincidence that these same populations experiencing the highest number of HIV infections are disproportionately likely to be uninsured and are also much less likely to access PrEP therapy than white Americans.Reference Cohen, Terlizzi, Cha and Martinez 3 Recent CDC data found 17% of transgender women surveyed had no insurance. 4 A plan must also factor in the challenges of addressing the needs of key populations across several different geographic settings, including following expert guidance to leverage telehealth for PrEP in rural areas which also experience significant racial and gender disparities in HIV outcomes.

There is no chance of success in addressing HIV in the United States without reducing disparities in coverage and PrEP access. It follows that any national PrEP access program, such as the one proposed by Killelea and colleagues,Reference Killelea 5 must consider and address unique barriers for the most affected communities from conception all the way through implementation with a constant focus on race and ethnicity, gender, sexual identify, and geographic settings including rural communities. Precedent exists for highly accessible PrEP programs in nontraditional settings that can disproportionately benefit communities that are generally excluded from interventions; however, previous successful examples highlight the importance of quality provider services and simultaneously addressing several financial, social, and structural barriers for priority populations.Reference Pathela, Jamison, Blank, Daskalakis, Hedberg and Borges 6 This commentary outlines specific considerations for Black communities, Hispanic/Latino communities, and transgender and gender diverse (TGD) communities.

PrEP Access for Transgender and Gender Diverse People

The increased rates of HIV among TGD people, compared to the U.S. general population, are due to multiple contributing factors, but many have a foundation in the high rates of societal stigma and discrimination faced by TGD individuals.Reference White Hughto, Reisner and Pachankis 7 HIV screening and sexual health programs provide important entry points to PrEP; however, these are underutilized by TGD populations. Since 2006, the Centers for Disease Control and Prevention (CDC) has recommended that persons at high risk for HIV infection undergo HIV screening at least annually,Reference Branson, Handsfield, Lampe, Janssen, Taylor, Lyss and Clark 8 but this has been found to be suboptimal among transgender men and women with only one-third ever screening for HIV.Reference Pitasi, Oraka, Clark, Town and DiNenno 9 In addition to avoidance of health services due to experiences of or anticipation of discrimination,Reference Grant, Mottet and Tanis 10 transgender individuals may not be adequately screened for extragenital STIs, which are often asymptomatic.

Additional factors related to low PrEP uptake include challenges related to health education and literacy including low rates of knowledge, low HIV risk perception, PrEP stigma and concerns about antiviral drug interactions with hormones and lack of inclusion in PrEP campaigns.Reference Fisher, Fried, Desmond, Macapagal and Mustanski 11 There are limited studies that have evaluated PrEP persistence in TGD populations; however, one study revealed lower persistence among transgender women compared to cisgender men.Reference Spinelli, Scott, Vittinghoff, Liu, Gonzalez, Morehead-Gee, Gandhi and Buchbinder 12

Actions to increase PrEP uptake and persistence among TGD populations will require a multifaceted approach, including ensuring that medical systems and provider networks are welcoming to TGD individuals, clinicians are trained in culturally competent care, and that TGD persons at risk for HIV are provided with appropriately tailored information about HIV prevention interventions. HIV PrEP campaigns must be inclusive of and responsive to concerns of TGD persons, including explicit statements that PrEP will not decrease hormone levels.

Informed decision making about PrEP should include information about the available PrEP options, and a discussion about how to extrapolate results from studies that have been predominately conducted in cisgender populations to TGD people. One example is that event-driven PrEP has not been studied in TGD populations or in individuals assigned female at birth. Long-acting cabotegravir, studied in HPTN 083 and 084 did not include transgender men or individuals with known silicone or soft tissue fillers in the buttocks, which predominately impacts feasibility of cabotegravir injections for transgender women. In the future, it is important that all clinical trials of HIV prevention agents should be inclusive of TGD populations, including nonbinary persons, to assess effectiveness, feasibility, and acceptability.

PrEP Access for Black Communities

The subpar utilization of PrEP among Black communities is symbolic of the ways America has lacked the will and capacity to effectively respond to the HIV crisis among Black communities. When PrEP was approved by the FDA in 2012, it was touted as a game-changing intervention for ending the HIV epidemic without a vaccine or cure. Yet, utilization among key populations in Black communities not only lags behind their racial peers, but dramatically widens the disparities of who will end their HIV epidemic by 2030 and those who will not. Black women are disproportionately impacted as well, making up 60% of new infections in women despite making up only 15% of women overall.Reference Ojikutu and Mayer 13

Research has shown that barriers to PrEP utilization among Black communities include a multitude of racial and socio-economic factors including: lack of awareness; poverty; systemic racism; and culturally incompetent healthcare providers and systems.Reference Ojikutu, Bogart, Higgins-Biddle, Dale, Allen, Dominique and Mayer 14 Black women in particular face challenges with awareness of PrEP, given that PrEP messaging is often not geared toward their particular messaging needs.Reference Ojikutu and Mayer 15 Research points to effective structural interventions to respond to these intersectional issues that are driven by anti-Black systems. A national PrEP program that effectively reaches the most disenfranchised communities must respond not only to healthcare delivery issues, but long-standing racial and gender issues that span across various American systems that are traditionally viewed as non-healthcare issues. An effective program will be intersectional in its approach and address the factors that put some at higher risk of HIV acquisition than others.

A national PrEP program that effectively reaches the most disenfranchised communities must respond not only to healthcare delivery issues, but long-standing racial and gender issues that span across various American systems that are traditionally viewed as non-healthcare issues. An effective program will be intersectional in its approach and address the factors that put some at higher risk of HIV acquisition than others.

Access to quality healthcare is a facilitator of PrEP utilization. The first entryway to quality healthcare is universal healthcare coverage regardless of one’s ability to pay. While the proposal presented by Killelea and colleagues offers a pathway to immediate expanded and free access to comprehensive PrEP coverage, this is just one piece in the broader fight for comprehensive healthcare access. Providers in Black communities must also be trained to understand and ultimately believe in the efficacy and impact of PrEP in ending new HIV cases while also being continually engaged in a process that facilitates cultural humility to effectively reach Black individuals that would benefit from PrEP. Research in recent years has shown that acceptance of preventive healthcare services is more successful in Black patients when they are provided by Black providers and by programs designed by and for Black communities,Reference Alsan, Garrick and Graziani 16 something that likely factored into the successes of the PrEP demonstration project HPTN 073.Reference Wheeler, Fields, Beauchamp, Chen, Emel, Hightow‐Weidman and Hucks‐Ortiz 17 Any national PrEP program would have to focus ongoing resources towards provider education and diversification of the healthcare and public health workforce in communities most impacted by HIV.

Health literacy and awareness about PrEP among Black communities continues to be an ongoing barrier nearly a decade after approval from the FDA. Health education and campaigns from CDC have not created broad awareness, and commercials from pharmaceutical companies have not led to a decrease in racial disparities among PrEP usage. Corporate campaigns may also have reinforced community beliefs that PrEP is something only gay men should use. The Black population of America is not monolithic; a national PrEP campaign must include wide-scale, culturally relevant marketing campaigns that respond to the concerns and motivations of a diverse group of populations within the Black community and also aim to reduce HIV stigma, homophobia, and transphobia. A national plan must also intentionally engage Black cisgender women who are not always aware that PrEP exists for them and often face high barriers when engaging clinicians for PrEP.

A national PrEP program must respond to structural issues that impact PrEP utilization along racial lines. Fundamental challenges like poverty, intimate partner violence, and a lack of housing all have deleterious effects on PrEP utilization. Structural interventions such as universal income and housing support have been shown to have positive impacts on health care seeking behavior. Linking PrEP access to programs that address these critical drivers of health disparities, and further strengthening participating organizations through financial incentives will better integrate PrEP into addressing the holistic wellness of Black communities most in need of comprehensive HIV prevention services.

PrEP Access for Hispanic/Latinx Communities

As with TGD and Black communities, a broad range of socioeconomic and social barriers inhibit PrEP access in Latinx communities. Additionally, linguistic barriers and documentation requirements can make programs impossible to access for vulnerable Hispanic/Latinx individuals. A national PrEP access program that dramatically expands access points, nearly eliminates paperwork, and factors in culturally and linguistically relevant provider education and community promotion and health literacy will facilitate greater PrEP uptake in Hispanic/Latinx communities.

However, even as a national program is implemented, close monitoring and research will be urgently needed to better understand differential PrEP uptake among Black and Latinx communities with a particular focus on MSM. In studies that ask participants about PrEP interest and acceptability, reported willingness to adopt PrEP among Black and Latino MSM is as high (if not higher) than that reported by white and other MSM.Reference Mansergh, Koblin and Sullivan 18 However, hypothetical interest is not the same as real-world willingness, which is impacted not only by “objective” factors such as PrEP awareness/knowledge, but also by underlying attitudes and beliefs that influence comprehension and interpretation of any PrEP education.

In addition, PrEP availability is not the same as access. In order to be truly accessible, PrEP programs must be available to highest priority individuals within the settings in which they are most likely to receive care and in a manner that is financially affordable. As such, close monitoring and evaluation will help identify where and why PrEP access is lagging.

Emerging research also points to the important role of providers in PrEP implementation. Meaningful PrEP access for patients happens both before and after they express interest in PrEP.Reference Ayala, Makofane, Santos, Beck, Do, Hebert, Wilson, Pyun and Arreola 19 Many patients learn about PrEP for the first time from their medical providers, while others report that their providers have been a barrier to PrEP prescription. Comprehensive PrEP implementation requires increasing patient-provider communication about HIV prevention and ensuring that providers serving highest priority populations are willing and able to offer PrEP to them. Another recent study showed that community-based and culturally informed interventions can help overcome financial and insurance barriers to boost PrEP access among Latino or Hispanic sexual minority men.Reference Kuehn 20

Recommendations and Conclusions

To address racial, ethnic and gender inequities via a national PrEP access program, and building off of the innovative approach presented by Killelea and colleagues, at least a few common themes emerge:

  1. Intentionality: a program must be designed specifically with racial, ethnic and gender equity in mind. Federal, state, and local implementers should continually consider if vulnerable Black, Latinx, transgender, and gender diverse communities are likely to benefit in rural, suburban, and urban contexts.

  2. Financial transparency and accountability: program budgets should transparently account for the costs of a national PrEP program in a way that demonstrates that the intersectional needs of communities that need PrEP the most are being identified and properly resourced.

  3. Representation matters: PrEP programs designed by and for the communities they aim to serve have been shown to be highly effective. In order to be strategic, any federal and health department leadership for a PrEP access program must reflect racially, ethnically and gender diverse communities. An expanded provider network must be shown to increase the number of Black, Latinx, and transgender providers offering services.

  4. Effective community outreach: innovative messaging approaches must be pursued as knowledge of PrEP has not fully permeated vulnerable communities. Messages by and for current and potential PrEP users from priority populations will help reflect the key messages and address any linguistic barriers that prevent uptake of key information.

  5. Effective provider education: In addition to receiving basic clinical guidance, any extended provider network established through a national PrEP access program must be effectively educated on unique barriers to uptake and access for Black, Latinx, and transgender populations.

  6. Socioeconomic factors: PrEP access must be specifically paired with services that help to combat socioeconomic risk factors for vulnerable populations such as low income, unstable housing, and unsafe living environments. This should be considered in recruitment of a provider network, with specific emphasis on organizations that focus on these overlapping services across several geographic settings.

  7. Ongoing research: Implementation of a federally coordinated access program should partner with NIH to study the effectiveness of scale up for Black, Hispanic/Latinx, and transgender populations, any persistent barriers to uptake, and potential extrapolation to other hard to access preventive healthcare services (e.g., Narcan). Implementation science must be prioritized to ensure we are documenting the successes and challenges of such a program.

Note

Jeremiah Johnson provided consulting services to Johns Hopkins University during the conduct of the study.

References

Bosh, K.A., Hall, H.I., Eastham, L., Daskalakis, D.C., and Mermin, J.H., “Estimated Annual Number of HIV Infections: United States, 1981–2019,” Morbidity and Mortality Weekly Report 70, no. 22 (2021): 801.CrossRefGoogle ScholarPubMed
Cohen, R.A., Terlizzi, E.P., Cha, A.E., and Martinez, M.E., Health Insurance Coverage: Early Release of Estimates from the National Health Interview Survey, 2020 (2021), available at <https://www.cdc.gov/nchs/data/nhis/earlyrelease/insur202108-508.pdf> (last visited April 1, 2022).+(last+visited+April+1,+2022).>Google Scholar
Centers for Disease Control and Prevention, “HIV Infection, Risk, Prevention, and Testing Behaviors among Transgender Women–National HIV Behavioral Surveillance, 7 US cities, 2019–2020,” Surveillance Special Report 27 (2021), available at <https://www.cdc.gov/hiv/pdf/library/reports/surveillance/cdc-hiv-surveillance-special-report-number-27.pdf> (last visited April 1, 2022).+(last+visited+April+1,+2022).>Google Scholar
Killelea, A., “Financing and Delivering Pre-Exposure Prophylaxis (PrEP) to End the HIV Epidemic,” Journal of Law, Medicine & Ethics 50, no. 2, Suppl. (2022): 823.Google Scholar
Pathela, P., Jamison, K., Blank, S., Daskalakis, D., Hedberg, T., and Borges, C., “The HIV Pre-exposure Prophylaxis (PrEP) Cascade at NYC Sexual Health Clinics: Navigation Is the Key to Uptake,” JAIDS Journal of Acquired Immune Deficiency Syndromes 83, no. 4 (2020): 357364.CrossRefGoogle Scholar
White Hughto, J.M., Reisner, S.L., and Pachankis, J.E., “Transgender Stigma and Health: A Critical Review of Stigma Determinants, Mechanisms, and Interventions,” Society of Science & Medicine 147 (2015): 222231.CrossRefGoogle Scholar
Branson, B.M., Handsfield, H.H., Lampe, M.A., Janssen, R.S., Taylor, A.W., Lyss, S.B., and Clark, J.E., “Revised Recommendations for HIV Testing of Adults, Adolescents, and Pregnant Women in Health-Care Settings,” MMWR Recommendations and Reports 55 (2006): (Rr-14), 117; quiz CE11-14.Google ScholarPubMed
Pitasi, M.A., Oraka, E., Clark, H., Town, M., and DiNenno, E.A., “HIV Testing among Transgender Women and Men - 27 States and Guam, 2014-2015,” MMWR Morbidity and Mortality Weekly Report 66, no. 33 (2017): 883887.CrossRefGoogle ScholarPubMed
Grant, J.M., Mottet, L.A., and Tanis, J., National Transgender Discrimination Survey Report on Health and Health Care (2010).Google Scholar
Fisher, C.B., Fried, A.L., Desmond, M., Macapagal, K., and Mustanski, B., “Perceived Barriers to HIV Prevention Services for Transgender Youth,” LGBT Health 5, no. 6 (2018): 350358; C.T. Rael, M. Martinez, R. Giguere, W. Bockting, C. MacCrate, W. Mellman, P. Valente, G.J. Greene, S. Sherman, K.H.A. Footer, R.T. D’Aquila, and A. Carballo-Dieguez, (2018). “Barriers and Facilitators to Oral PrEP Use Among Transgender Women in New York City,” AIDS Behavior 22, no. 11 (2018): 3627-3636; J.M. Sevelius, J. Keatley, N. Calma, and E. Arnold, (2016). “‘I Am Not a Man’: Trans-Specific Barriers and Facilitators to PrEP Acceptability among Transgender Women,” Global Public Health 11, nos. 7-8 (2015): 1060-1075; E.C. Wilson, H. Jin, A. Liu, and H.R. Raymond, “Knowledge, Indications and Willingness to Take Pre-Exposure Prophylaxis among Transwomen in San Francisco, 2013,” PloS One 10, no. 6 (2015): e0128971.CrossRefGoogle ScholarPubMed
Spinelli, M.A., Scott, H.M., Vittinghoff, E., Liu, A.Y., Gonzalez, R., Morehead-Gee, A., Gandhi, M., and Buchbinder, S.P., “Missed Visits Associated with Future Preexposure Prophylaxis (PrEP) Discontinuation among PrEP Users in a Municipal Primary Care Health Network,” Open Forum Infectious Disease 6, no. 4 (2019): ofz101.CrossRefGoogle Scholar
Ojikutu, B.O. and Mayer, K., “HIV Prevention among Black Women in the US — Time for Multimodal Integrated Strategies,” JAMA Network Open 4, no. 4 (2021): e215356e215356.CrossRefGoogle ScholarPubMed
Ojikutu, B.O., Bogart, L.M., Higgins-Biddle, M., Dale, S.K., Allen, W., Dominique, T., and Mayer, K.H., “Facilitators and Barriers to Pre-exposure Prophylaxis (PrEP) Use among Black Individuals in the United States: Results from the National Survey on HIV in the Black Community (NSHBC),” AIDS and Behavior 22, no. 11 (2018): 35763587.CrossRefGoogle Scholar
Ojikutu, B.O. and Mayer, K.H., “Hidden in Plain Sight: Identifying Women Living in the United States Who Could Benefit from HIV Preexposure Prophylaxis,” Journal of Infectious Diseases 222, no. 9 (2020): 14281431.CrossRefGoogle ScholarPubMed
Alsan, M., Garrick, O., and Graziani, G., “Does Diversity Matter for Health? Experimental Evidence from Oakland,” American Economic Review 109, no. 12 (2019): 4071-4111.CrossRefGoogle Scholar
Wheeler, D.P., Fields, S.D., Beauchamp, G., Chen, Y.Q., Emel, L.M., Hightow‐Weidman, L., Hucks‐Ortiz, C. et al., “Pre‐exposure Prophylaxis Initiation and Adherence among Black Men Who Have Sex with Men (MSM) in Three US Cities: Results from the HPTN 073 Study,” Journal of the International AIDS Society 22, no. 2 (2019): e25223.CrossRefGoogle ScholarPubMed
Mansergh, G., Koblin, B.A., and Sullivan, P.S., “Challenges for HIV Pre-exposure Prophylaxis among Men Who Have Sex with Men in the United States,” PloS Medicine 9, no. 8 (2012): e1001286.CrossRefGoogle ScholarPubMed
Ayala, G., Makofane, K., Santos, G.-M., Beck, J., Do, T.D., Hebert, P., Wilson, P.A., Pyun, T., and Arreola, S., “Access to Basic HIV-Related Services and PrEP Acceptability among Men Who Have Sex with Men Worldwide: Barriers, Facilitators, and Implications for Combination Prevention,” Journal of Sexually Transmitted Diseases 2013 (2013).CrossRefGoogle ScholarPubMed
Kuehn, B.M., “Low PrEP Awareness, Referrals for Black, Hispanic, and Latino People,” JAMA 326, no. 18 (2021): 17861786.Google ScholarPubMed